▲ SIGMATERMINAL Open Terminal →

Analyses / TEAM

TEAM Atlassian Corp As of Jul 24, 2026
$80.15

High-growth SaaS under pressure: strong revenue trajectory vs. margin headwinds and insider selling.

Setup: Recovery / Rotation Play Confidence: 55 Horizon: 3–6 months Risk: High Category: Growth / SaaS
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals TEAM's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

23% YoY revenue growth + 26.4% CAGR (5Y) show strong demand for collaboration tools. 82.8% gross margin indicates pricing power. P/S 3.9x below SaaS peers (5–8x); if profitability inflects, multiple re-rating likely. AI-augmented features (Atlassian Intelligence) driving upsell and retention.

▼ Bear Case

-2.5% operating margin + -4.9% net margin = unprofitable at scale. EV/EBITDA -181x signals near-break-even or EBITDA destruction. Heavy insider selling (1,713 sells vs. 32 buys) suggests management skepticism. Stock down 61% from 52w high ($206); risk of further mean reversion if growth decelerates or losses persist.

Valuation

OVERVALUED on absolute metrics; FAIRLY VALUED if growth sustains and path to profitability materializes — score 55/100

P/S 3.9x appears reasonable for 23% growth SaaS; however, negative margins (Op -2.5%, Net -4.9%) and elevated P/B 44.9x inject significant risk. Valuation is forward-looking, pricing in AI and margin recovery.

Technical Levels

Support · $75.00 (Recent swing low / entry zone floor) · $70.00 (Stop loss level) · $56.00 (52w low (washout risk))

Resistance · $87.70 (Today's high) · $100.00 (Psychological round) · $130.00 (Mid-range recovery target) · $206.00 (52w high (strong headwind))

RSI: Not provided by source

Financial Health

Score 62/100. Solid liquidity; no immediate solvency risk. However, structural unprofitability raises questions on long-term sustainability. SaaS model supports cash generation, but margin path is murky.

Catalysts

Next earnings release (Q & guidance)Unknown from provided data; typically quarterlyHigh — margin trend, revenue guidance, and AI monetization key. Beat on profitability could trigger +15–20% rerating.
AI upsell metrics disclosed (ARR per customer, adoption)Likely in next earnings or investor updateHigh — validates AI-as-accelerator narrative or reveals hype overshoot.
Insider buying resumption or large block purchaseNo timeline; signal would matter for sentiment resetMedium — would contradict heavy recent selling and bolster confidence.
Margin inflection (operating margin → +2–5%)2–4 quarters out; depends on operating leverageHigh — derisks valuation and unlocks SaaS multiple expansion.
Sector rotation (SaaS inflows if rates fall or AI enthusiasm peaks)Macro-driven; 1–3 monthsHigh — could lift entire cohort 10–20%; TEAM could move to $95–110 on sector momentum.

Risk Flags

Negative operating & net margins despite scale; path to profitability unclear from provided data.
Massive insider net selling: 1,713 sales vs. 32 buys. Confidence-negative signal.
52w drawdown 61% ($206→$80); recovery thesis depends on multiple expansion or earnings inflection.
P/B 44.9x is extremely elevated; intangible value at risk if growth slows or sentiment turns.
Provider data lacks recent earnings, guidance, subscriber metrics, or churn; full visibility limited.

See TEAM's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock TEAM free →

Recent News

More Analyses

TEAM FAQ

Is TEAM a buy right now?

Atlassian Corp's current read is a Recovery / Rotation Play setup with 55 confidence over a 3–6 months horizon. Valuation: OVERVALUED on absolute metrics; FAIRLY VALUED if growth sustains and path to profitability materializes. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is TEAM overvalued?

OVERVALUED on absolute metrics; FAIRLY VALUED if growth sustains and path to profitability materializes (valuation score 55/100). P/S 3.9x appears reasonable for 23% growth SaaS; however, negative margins (Op -2.5%, Net -4.9%) and elevated P/B 44.9x inject significant risk. Valuation is forward-looking, pricing in AI and margin recovery.

What are the risks of buying TEAM?

-2.5% operating margin + -4.9% net margin = unprofitable at scale. EV/EBITDA -181x signals near-break-even or EBITDA destruction. Heavy insider selling (1,713 sells vs. 32 buys) suggests management skepticism. Stock down 61% from 52w high ($206); risk of further mean reversion if growth decelerates or losses persist.